Notch1 Drives the Formation and Proliferation of Intrahepatic Cholangiocarcinoma

Abstract

The molecular mechanisms underlying the development of intrahepatic cholangiocarcinoma (ICC) are not clear yet. In this study, we investigated the involvement of Notch1 in the development of ICC. The cDNA microarray analysis showed that Notch1 expression was higher in ICC tissues than in normal biliary epithelial cells. Stable transfection of Notch1 receptor intracellular domain (NICD1) by hydrodynamic tail vein injection induced ICC formation in mice. Western blotting confirmed that Notch1 signaling was activated in human ICC cell lines and mouse ICC tissues. Silencing Notch1 with specific short interfering RNA (siRNA) inhibited the proliferation of ICC cells. Flow cytometry and Western blotting indicated that apoptosis was induced in Notch1-silenced ICC cells compared with controls. Additionally, Notch1 silencing was associated with the inhibition of hairy and enhancer of split-1 (Hes1) and activation of the phosphatase and tensin homolog (PTEN)/p53 pathway. Taken together, these data suggest that Notch1 drives ICC formation and proliferation; downregulation of Notch1 induces apoptosis in ICC cells; Notch1 signaling may serve as a novel therapeutic target for the treatment of ICC.

Keywords

Notch1 / hydrodynamic transfection / intrahepatic cholangiocarcinoma

References

[1] ZhaoQ, YuWL, LuXY, et al.. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study. Chin J Cancer, 2016, 35(1): 82-90

[2] RazumilavaN, GoresGJ. Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol, 2013, 11(1): 13-21

[3] Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet, 2014:2168–2179

[4] WangFS, FanJG, ZhangZ, et al.. The global burden of liver disease: the major impact of China. Hepatology, 2014, 60(6): 2099-2108

[5] EsnaolaNF, MeyerJE, KarachristosA, et al.. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer, 2016, 122(9): 1349-1369

[6] PapatheodoridisGV, LamperticoP, ManolakopoulosS, et al.. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol, 2010, 53(2): 348-356

[7] AlvesRC, AlvesD, GuzB, et al.. Advanced hepatocellular carcinoma: Review of targeted molecular drugs. Ann Hepatol, 2011, 10(1): 21-27

[8] BelinaF. Hilar cholangiocarcinoma (Klatskin tumor) - current treatment options. Rozhl Chir, 2013, 92: 4-15

[9] YuY, WangL, TangW, et al.. RNA interference-mediated knockdown of Notch-1 inhibits migration and invasion, down-regulates matrix metalloproteinases and suppresses NF-kappaB signaling pathway in trophoblast cells. Acta Histochem, 2014, 116(5): 911-919

[10] PupoM, PisanoA, AbonanteS, et al.. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs). Int J Biochem Cell Biol, 2014, 46: 56-67

[11] DahanS, RabinowitzKM, MartinAP, et al.. Notch-1 signaling regulates intestinal epithelial barrier function, through interaction with CD4+ T cells, in mice and humans. Gastroenterology, 2011, 140: 550-559

[12] JensenJ, PedersenEE, GalanteP, et al.. Control of endodermal endocrine development by Hes-1. Nat Genet, 2000, 24(1): 36-44

[13] SunYY, LiL, LiuXH, et al.. The spinal notch signaling pathway plays a pivotal role in the development of neuropathic pain. Mol Brain, 2012, 5: 23-32

[14] TakebeN, NguyenD, YangSX. Targeting notch signaling pathway in cancer: clinical development advances and challenges. Pharmacol Ther, 2014, 141(2): 140-149

[15] WolpinBM, MayerRJ. A step forward in the treatment of advanced biliary tract cancer. N Engl J Med, 2010, 362(14): 1335-1337

[16] BinatoM, SchmidtMK, VolkweisBS, et al.. Mouse model of diethylnitrosamine-induced gastric cancer. J Surg Res, 2008, 148(2): 152-157

[17] YangH, LiTW, PengJ, et al.. A mouse model of cholestasis-associated cholangiocarcinoma and transcription factors involved in progression. Gastroenterology, 2011, 141(1): 378-388

[18] JuHL, HanKH, LeeJD, et al.. Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anticancer therapy. Int J Cancer, 2016, 138(1): 1601-1608

[19] CalvisiDF, WangC, HoC, et al.. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology, 2011, 140(3): 1071-1083

[20] ChenX, CalvisiDF. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am J Pathol, 2014, 184(4): 912-923

[21] WangY, WangY, ZhangL, et al.. Endonuclease Restriction-Mediated Real-Time Polymerase Chain Reaction: A Novel Technique for Rapid, Sensitive and Quantitative Detection of Nucleic-Acid Sequence. Front Microbiol, 2016, 7: 1104-1114

[22] YuanX, WuH, XuH, et al.. Notch signaling: an emerging therapeutic target for cancer treatment. Cancer Lett, 2015, 369(1): 20-27

[23] KopanR, IIaganMX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell, 2009, 137(2): 216-233

[24] FanB, MalatoY, CalvisiDF, et al.. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest, 2012, 122(8): 2911-2915

[25] O’NeilJ, CalvoJ, McKennaK, et al.. Activating Notch1 mutations in mouse models of T-ALL. Blood, 2006, 107(2): 781-785

[26] YanXQ, SarmientoU, SunY, et al.. A novel Notch ligand, Dll4, induces T-cell leukemia/lymphoma when overexpressed in mice by retroviral-mediated gene transfer. Blood, 2001, 98(13): 3793-3799

[27] AllenTD, RodriguezEM, JonesKD, et al.. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. Cancer Res, 2011, 71(18): 6010-6018

[28] WangZ, Da SilvaTG, JinK, et al.. Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma. Cancer Res, 2014, 74(21): 6364-6374

[29] GallahanD, CallahanR. The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene, 1997, 14(16): 1883-1890

[30] DillMT, TornilloL, FritziusT, et al.. Constitutive Notch2 signaling induces hepatic tumors in mice. Hepatology, 2013, 57(4): 1607-1619

[31] TaloraC, SgroiDC, CrumCP, et al.. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev, 2002, 16(17): 2252-2263

[32] Zweidler-McKayPA, HeY, XuL, et al.. Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood, 2005, 106(12): 3898-3906

[33] AsterJC, PearWS, BlacklowSC. The Varied Roles of Notch in Cancer. Annu Rev Pathol, 2017, 12: 245-275

[34] BolosV, Grego-BessaJ, de la PompaJL. Notch signaling in development and cancer. Endocr Rev, 2008, 28(3): 339-363